venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leukemia, lymfosyyttinen, krooninen, b-solu - antineoplastiset aineet - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
xydalba
abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - systeemiset bakteerilääkkeet, - akuuttien bakteerien iho- ja ihorakenteiden infektiot (absssi) hoito aikuisilla.
fml liquifilm 1 mg/ml silmätipat, suspensio
abbvie oy - fluorometholone - silmätipat, suspensio - 1 mg/ml - fluorometoloni
pred forte 10 mg/ml silmätipat, suspensio
abbvie oy - prednisolone acetate - silmätipat, suspensio - 10 mg/ml - prednisoloni
exocin 3 mg/ml silmätipat, liuos
abbvie oy - ofloxacin - silmätipat, liuos - 3 mg/ml - ofloksasiini
alphagan 0,2 % (2 mg/ml) silmätipat, liuos
abbvie oy - brimonidine tartrate - silmätipat, liuos - 0,2 % (2 mg/ml) - brimonidiini
celluvisc 1.0 % silmätipat, liuos, kerta-annospakkaus
abbvie oy - carboxymethylcellulose sodium - silmätipat, liuos, kerta-annospakkaus - 1.0 % - keinokyyneleet ja muut luokittelemattomat valmisteet
chirocaine 0.625 mg/ml infuusioneste, liuos
abbvie oy - levobupivacaine hydrochloride - infuusioneste, liuos - 0.625 mg/ml - levobupivakaiini
chirocaine 1.25 mg/ml infuusioneste, liuos
abbvie oy - levobupivacaine hydrochloride - infuusioneste, liuos - 1.25 mg/ml - levobupivakaiini
moderiba 200 mg tabletti, kalvopäällysteinen
abbvie oy - ribavirinum - tabletti, kalvopäällysteinen - 200 mg - ribaviriini